Puma Biotechnology
Puma Biotechnology, Inc.
News Release
Should You Buy Puma Biotechnology Inc (PBYI) Stock Tuesday?
Puma Bio Bulls Win Monday's FDA Neratinib Review, Ahead of Wednesday's Advisory Panel Vote - TheStreet
The Prognosis For Puma Biotechnology (NASDAQ:PBYI) | Seeking Alpha
Why Puma Biotechnology Is Soaring Today | The Motley Fool
Puma Biotechnology - Updates, News, Events, Signals & Triggers
PumaBiotech (@pumabiotech) / Twitter
Here's Why Puma Biotechnology Fell 17.2% in April | The Motley Fool
Is Puma off the cancer M&A list? With Nerlyx marketing deal, some investors think so | Fierce Pharma
Puma Biotechnology Secures $125 Million Note Purchase by Athyrium Capital | Business Wire
Former Puma Biotech executive gets U.S. prison term for insider trading | Reuters.com
Puma Biotechnology (Nasdaq:PBYI) - Stock Price, News & Analysis - Simply Wall St
Puma Biotechnology (PBYI) Stock Climbs On Orphan Drug Designation | Alpha Stock News
Puma Biotechnology | $PBYI Stock | Shares Climb Up as Company Announced FDA Approval for NERLYNX - Warrior Trading News
PUMA BIOTECHNOLOGY, INC. FORM 10-K - Biotech Due Diligence
Puma Biotechnology Announces Publication of Phase II Clinical Trial of Alisertib in JAMA Oncology | Business Wire
Puma Biotechnology Surging
Puma Biotechnology up 15% after quarterly earnings beats (NASDAQ:PBYI) | Seeking Alpha
Alan H. Auerbach - Los Angeles Business Journal
Conspiracy Theory: Did Puma Biotech Exec Resign Because of Bad News Ahead? | BioSpace
Why Puma Biotechnology, Inc. Stock Crashed 37% in March | Fox Business
Puma Biotechnology - Updates, News, Events, Signals & Triggers
Puma Biotechnology Inc
Stocks to Watch: Dropbox, Nike, Tronc, Qualcomm, Puma Biotechnology, Invitation Homes, Universal Display - WSJ
Puma Biotechnology Executives Under Investigation for Breast Cancer Drug — Schubert Jonckheer & Kolbe
